Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.

Quotes for Spermosens AB (publ)

Right Now

+/-
0.2
%
1,47%
Latest
13.8
High
14.4
Low
13.42
Volume
30 172
Turnover (SEK)
412 225
Market Value (MSEK)
167,2
Time (Latest trade)
2022-07-07 17:11

Board

CEO

  • John Lempert

Chairperson of the Board

  • Eva Nilsagård

Board

  • Christina Östberg Lloyd
  • Ingela Liljeqvist Soltic
  • Kushagr Punyani
  • Sören Melsing Frederiksen

Videos

Largest Owners

Name Capital % Votes % Date
Kushagr Punyani 13,03 13,03 2022-05-25
Avanza Pension 10,09 10,09 2022-03-31
Mohamad Takwa 8,55 8,55 2022-03-31
Emelie Takwa 4,25 4,25 2022-03-31
Nordnet Pensionsförsäkring 4,15 4,15 2022-03-31
John Moll 2,20 2,20 2021-12-31
Massimiliano Franzé 2,14 2,14 2022-03-31
Søren Melsing Frederiksen 2,09 2,09 2021-12-31
Darren Glover 1,48 1,48 2021-12-31
Philip Rasmusson 1,46 1,46 2022-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-07-14 Delårsrapport 2022-Q2

  • 2022-10-14 Delårsrapport 2022-Q3